227
Views
4
CrossRef citations to date
0
Altmetric
OBSTETRICS

Relationships among acylation-stimulating protein, insulin resistance, lipometabolism, and fetal growth in gestational diabetes mellitus women

, , , , &

Reference

  • Ahren B, Havel PJ, Pacini G, Cianflone K. 2003. Acylation stimulating protein stimulates insulin secretion. International Journal of Obesity and Related Metabolic Disorders 27:1037–1043.
  • Barker DJ. 2004. Developmental origins of adult health and disease. Journal of Epidemiology and Community Health 58:114–115.
  • Barker DJ. 2005. The developmental origins of insulin resistance. Hormone Research 64(Suppl 3):2–7.
  • Ben-Haroush A, Yogev Y, Hod M. 2004. Epidemiology of gestational diabetes mellitus and its association with Type 2 diabetes. Diabetic Medicine 21:103–113.
  • Boden G. 1999. Free fatty acids, insulin resistance, and type 2 diabetes mellitus. Proceedings of the Association of American Physicians 111: 241–248.
  • Butte NF. 2000. Carbohydrate and lipid metabolism in pregnancy: normal compared with gestational diabetes mellitus. American Journal of Clinical Nutrition 71:1256S–1261S.
  • Cianflone K. 2003. Acylation stimulating protein and triacylglycerol synthesis: potential drug targets? Current Pharmaceutical Design 9: 1397–1410.
  • Cianflone K, Maslowska M. 1995. Differentiation-induced production of Asp in human adipocytes. European Journal of Clinical Investigation 25:817–825.
  • Cianflone K, Paglialunga S, Roy C. 2008. Intestinally derived lipids: metabolic regulation and consequences–an overview. Atherosclerosis 9:63–68.
  • Cianflone K, Roncari DA, Maslowska M, Baldo A, Forden J, Sniderman AD. 1994. Adipsin/acylation stimulating protein system in human adipocytes: regulation of triacylglycerol synthesis. Biochemistry 33:9489–9495.
  • Freeman DJ. 2010. Effects of maternal obesity on fetal growth and body composition: implications for programming and future health. Seminars in Fetal and Neonatal Medicine 15:113–118.
  • Gao Y, Gauvreau D, Cianflone K. 2010. Hormone and pharmaceutical regulation of Asp production in 3T3-L1 adipocytes. Journal of Cellular Biochemistry 109:896–905.
  • Giaginis C, Theocharis S, Tsantili-Kakoulidou A. 2012. Current toxicological aspects on drug and chemical transport and metabolism across the human placental barrier. Expert Opinion on Drug Metabolism and Toxicology 8:1263–1275.
  • Harlev A, Wiznitzer A. 2010. New insights on glucose pathophysiology in gestational diabetes and insulin resistance. Current Diabetes Reports 10:242–247.
  • Herrera E, Ortega-Senovilla H. 2010. Disturbances in lipid metabolism in diabetic pregnancy. Are these the cause of the problem? Best Practice and Research. Clinical Endocrinology and Metabolism 24:515–525.
  • Jansson T, Cetin I, Powell TL, Desoye G, Radaelli T, Ericsson A et al. 2006. Placental transport and metabolism in fetal overgrowth – a workshop report. Placenta 27(Suppl A):S109–S113.
  • Kehl RJ, Krew MA, Thomas A, Catalano PM. 1996. Fetal growth and body composition in infants of women with diabetes mellitus during pregnancy. Journal of Maternal-Fetal Medicine 5:273–280.
  • Koistinen HA, Vidal H, Karonen SL, Dusserre E, Vallier P, Koivisto VA et al. 2001. Plasma acylation stimulating protein concentration and subcutaneous adipose tissue C3 mRNA expression in nondiabetic and type 2 diabetic men. Arteriosclerosis, Thrombosis, and Vascular Biology 21:1034–1039.
  • Magnusson AL, Waterman IJ, Wennergren M, Jansson T, Powell TL. 2004. Triglyceride hydrolase activities and expression of fatty acid binding proteins in the human placenta in pregnancies complicated by intrauterine growth restriction and diabetes. Journal of Clinical Endocrinology and Metabolism 89:4607–4614.
  • Mahajan SD, Aalinkeel R, Singh S, Shah P, Gupta N, Kochupillai N. 2006. Endocrine regulation in asymmetric intrauterine fetal growth retardation. Journal of Maternal-Fetal and Neonatal Medicine 19: 615–623.
  • Maslowska M, Wang HW, Cianflone K. 2005. Novel roles for acylation stimulating protein/C3adesArg: a review of recent in vitro and in vivo evidence. Vitamins and Hormones 70:309–332.
  • Pezzarossa A, Orlandi N, Baggi V, Dazzi D, Ricciarelli E, Coppola F. 1996. Effects of maternal weight variations and gestational diabetes mellitus on neonatal birth weight. Journal of Diabetes and its Complications 10: 78–83.
  • Roy C, Paglialunga S, Fisette A, Schrauwen P, Moonen-Kornips E, St-Onge J et al. 2008. Shift in metabolic fuel in acylation-stimulating protein-deficient mice following a high-fat diet. American Journal of Physiology – Endocrinology and Metabolism 294:E1051–E1059.
  • Saleh J, Al-Riyami HD, Chaudhary TA, Cianflone K. 2008. Cord blood Asp is predicted by maternal lipids and correlates with fetal birth weight. Obesity (Silver Spring) 16:1193–1198.
  • Samra JS, Simpson EJ, Clark ML, Forster CD, Humphreys SM, Macdonald IA et al. 1996. Effects of epinephrine infusion on adipose tissue: interactions between blood flow and lipid metabolism. American Journal of Physiology 271:E834–E839.
  • Schaefer-Graf UM, Meitzner K, Ortega-Senovilla H, Graf K, Vetter K, Abou-Dakn M et al. 2011. Differences in the implications of maternal lipids on fetal metabolism and growth between gestational diabetes mellitus and control pregnancies. Diabetic Medicine 28:1053–1059.
  • Schrauwen P, Hesselink MK, Jain M, Cianflone K. 2005. Acylation- stimulating protein: effect of acute exercise and endurance training. International Journal of Obesity 29:632–638.
  • Son GH, Kwon JY, Kim YH, Park YW. 2010. Maternal serum triglycerides as predictive factors for large-for-gestational age newborns in women with gestational diabetes mellitus. Acta Obstetricia et Gynecologica Scandinavica 89:700–704.
  • Van Harmelen V, Reynisdottir S, Cianflone K, Degerman E, Hoffstedt J, Nilsell K et al. 1999. Mechanisms involved in the regulation of free fatty acid release from isolated human fat cells by acylation-stimulating protein and insulin. Journal of Biological Chemistry 274:18243–18251.
  • Wen Y, Wang H, Maclaren R, Lu H, Hu XF, Cianflone K. 2008. Sex steroid hormones induce acylation stimulating protein resistance in 3T3-L1 adipocytes. Journal of Cellular Biochemistry 105:404–413.
  • Yang Y, Lu HL, Zhang J, Yu HY, Wang HW, Zhang MX et al. 2006. Relationships among acylation stimulating protein, adiponectin and complement C3 in lean vs obese type 2 diabetes. International Journal of Obesity 30:439–446.
  • Yesilova Z, Ozata M, Oktenli C, Bagci S, Ozcan A, Sanisoglu SY et al. 2005. Increased acylation stimulating protein concentrations in nonalcoholic fatty liver disease are associated with insulin resistance. American Journal of Gastroenterology 100:842–849.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.